School of Medicine
Showing 1-40 of 40 Results
-
Holly Tabor
Associate Professor of Medicine (General Medical Disciplines) and, by courtesy, of Epidemiology and Population Health at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
Manjula Kurella Tamura
Professor of Medicine (Nephrology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests I am a clinical and health services investigator whose primary interest is in improving the quality of end-stage renal disease (ESRD) care among older adults. My previous and current work aims to describe outcomes (especially geriatric outcomes) in older patients and to compare the effectiveness of different ESRD management strategies on these outcomes.
-
Jane C. Tan
Professor of Medicine (Nephrology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research relates to issues pertaining to clinical kidney transplantation. We have ongoing studies on the following topics.
1. Renal senescence and kidney transplant, and chronic allograft nephropathy.
2. Living donor safety and response to uninephrectomy.
3. Biomarkers for post-transplant monitoring. -
Marilyn Tan
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly Interests Type 2 diabetes, obesity, insulin resistance
-
(Nicholas) Kenji Taylor
Instructor, Medicine - Primary Care and Population Health
Bio Dr. Taylor was born and raised in rural Kansas and Pennsylvania, the youngest of four children. He headed to the big city of Providence, RI to study Neuroscience, East Asian Studies and Entrepreneurship at Brown University. Following graduation, his short-lived career in finance took him to Los Angeles, London and Tokyo, before he decided medicine was how he could directly help others who needed it the most. He attended the University of Pennsylvania where he developed a passion for health disparities, social justice and community medicine in West Philadelphia. As a medical student, he founded the nationally-recognized Cut Hypertension Program (www.cuthypertension.org), a blood pressure screening, education and referral program partnered with African American barbershops. He completed residency and chief residency at UCSF prior to joining the Stanford faculty and Stanford-Intermountain Fellowship in Population Health, Delivery Science, and Primary Care.
Dr. Taylor is a family physician, researcher, implementer, activist and educator. He is excited about the potential for innovative care models, financing and technology to improve the health of underserved populations. He is also interested in HIV primary care, mentoring black men of color in medicine and medical education in community clinics. In addition to his primary care practice at Stanford Family Medicine, Dr. Taylor provides HIV, MAT and Hep C treatment at the Roots Community Health Center in East Oakland where he also leads the community health navigator program for complex care patients.
For fulfillment outside of medicine, he loves being a new dad, plays the violin, travels, spends time outdoors and enjoys cooking with friends and family.
For more information on The Cut Hypertension Program, please visit www.cuthypertension.org; IG - @cuthypertensionprogram; FB – The Cut Hypertension Program -
Melinda L. Telli, M.D.
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Valerie Teng
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Bio Dr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Jeffrey Teuteberg
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Bio Dr. Teuteberg is board certified in Cardiology and Heart Failure and Transplantation. He is currently the Section Chief of Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. He sees patients both in the clinic and in the hospital with advanced heart failure and who have received cardiac transplantation or mechanical circulatory support.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He will serve as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Associate Professor, Medicine - Primary Care and Population Health
Bio Dr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She is board-certified in Hospice and Palliative Medicine, Internal Medicine and Clinical Informatics. She joined the faculty at Stanford in 2017 after working at University of Pittsburgh Medical Center for 13 years. She currently sees palliative care patients in the inpatient setting and also provides palliative care to patients with heart and lung disease in clinic.
In addition, she is the medical informatics director for the Division of Primary Care and Population Health. -
Haluk Tezcan, MD
Adjunct Clinical Assistant Professor, Medicine - Oncology
Bio Clinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the development of Lexent Bio's liquid biopsy technology, first in response monitoring, overseeing scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director both in academia and private practice, he has firsthand understanding of unmet clinical needs of physicians and patients, and broad experience in clinical trial design and implementation.
He established the CA.RE.foundation, a cancer research foundation dedicated to enabling clinical trial execution across community oncology sites throughout the Northwest US. He’s independently built multiple software tools to help oncologists in the practical realities of their daily work.
Before Lexent Bio, he has served as Director of Translational Medicine at Genomic Health and as Vice President leading oncology development at Counsyl, integrating science with clinical product development. He is a steering committee member of the ASCO QOPI, a quality care initiative. -
David Thom
Clinical Professor, Medicine - Primary Care and Population Health
Bio Dr. Thom is a family medicine physician and PhD-trained epidemiologist, who has over 30 years of experience in clinical care, research and teaching, primarily at Stanford and at the University of California San Francisco (UCSF). Over the course of his career, Dr. Thom has conducted over 20 studies, in the areas of cardiovascular disease, women’s health, the doctor-patient relationship and on health coaching for patients with chronic disease. He has published over 100 peer-reviewed, original research articles and over a dozen book chapters and has presented his work at numerous national and international meetings. Dr. Thom recently served as the Vice Chair for Research in the UCSF Department of Family and Community Medicine from 2015 until his retirement from UCSF in 2018.
In addition to teaching medical students and residents, Dr. Thom has been a research and/or career mentor to over 50 students, residents, fellows and junior faculty members. He served as a core faculty member for the UCSF Primary Care Research Fellowship Program from 2014 to 2018.
Dr. Thom is currently a Clinical Professor of Medicine in the Division of Primary Care and Population Health at Stanford. He provides clinical care and teaches medical students at the Stanford Family Medicine clinic. As a family physician, Dr. Thom diagnoses and treats a wide range of conditions, provides preventive care for patients of all ages, and performs a variety of office procedures. -
Larry W. Thompson, Ph.D.
Professor (Research) of Medicine (Endocrinology, Gerontology, and Metabolism), Emeritus
Current Research and Scholarly Interests Dr. Thompsons interests include psychosocial treatments for individuals with bipolar disorder and /or other serious mental illnesses; cognitive/behavioral therapy for late-life depression; intervention research with culturally diverse individuals with depression; and psychophysiological research on stress & coping.
-
Rebecca Lauren Tisdale
Clinical Instructor, Medicine
Bio Becca Tisdale, MD, MPA is an internist and health services researcher with interests in global health cardiology and health systems. She received a B.A. with distinction in Human Biology from Stanford in 2009, followed by a master of public administration (MPA) joint degree from Sciences Po, Paris and the London School of Economics. She then matriculated at Columbia University College of Physicians and Surgeons for medical school, where she was active in global health activities, researching multidisciplinary teams in HIV care in Ethiopia and serving on the board of the student international health organization. As a global health track resident at Stanford, Becca spent time working in Rwanda through the Johnson and Johnson program and participated in the inaugural Women Leaders in Global Health conferences at Stanford and in London. In 2019-2020, she comprised one third of Stanford’s first all-woman internal medicine chief resident cohort. Outside of work, she enjoys all things French as well as running, both in races and after her toddler son.
-
Lucy Tompkins
Lucy Becker Professor in Medicine and of Microbiology and Immunology
Current Research and Scholarly Interests Genetic and cellular basis of pathogenicity of Helicobacter pylori. Molecular epidemiology, hospital epidemiology, quality improvement in healthcare associated infections.
-
Natalie Torok
Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center
Current Research and Scholarly Interests My laboratory has been focusing on the mechanism of liver fibrogenesis and the role of hepatocyte cell death in fibrogenic injury. We have demonstrated the intricate link between hepatocyte cell death, generation of apoptotic bodies and their phagocytosis by stellate cells triggering fibrogenic activation. Key to this was the activation of the NADPH oxidase and production of reactive oxidative species inducing stellate cell transdifferentiation and collagen I transcription (Gastroenterology, 2010).
We have expanded our work focusing on the role of non-phagocytic NADPH oxidases including NOX4 in dysregulating insulin responses and precipitating stress signaling in non-alcoholic steatohepatitis. (Gastroenterology, 2015). As patients with type II diabetes mellitus develop more progressive liver disease we are now studying how advanced glycation end products (AGEs) engage RAGE signaling in the liver and NADPH oxidase-mediated redox stress.
Our ultimate goal is to translate our findings and develop novel therapeutic approaches that reverse fibrosis in NASH and improve patient outcomes. -
De Tran
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Bio I would like to use the office visits as opportunities to engage the patients in participating in managing their well-being, and to bring them world-class Stanford Health Care.
-
Jennifer Tremmel
Susan P. and Riley P. Bechtel Medical Director and Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Tremmel studies sex differences in cardiovascular disease. Current research projects include evaluating sex differences in coronary pathophysiology, young patients presenting with myocardial infarction, the impact of stress on anginal symptoms, chronic total coronary occlusions, and vascular access site complications.
-
George Triadafilopoulos
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly Interests My primary research interest concerns factors involved in the pathogenesis of gastro-esophageal reflux disease and its complications, such as Barrett's esophagus and the role of diagnostic and therapeutic modalities in their management.
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests Our primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Geoffrey Tso
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests Clinical Informatics, Clinical Decision Support, Digital Health, Multimorbidity, Preventive Health, Telemedicine, Telehealth, Machine Learning, Artificial Intelligence
-
Minang (Mintu) Turakhia
Associate Professor of Medicine (Cardiovascular Medicine) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests Dr. Turakhia has an active clinical research program, with funding from AHA, VA, NIH, the medical device industry, and foundations. His research program aims to improve the treatment of heart rhythm disorders, with an emphasis on atrial fibrillation, by evaluating quality and variation of care, comparative and cost-effectiveness of therapies, and risk prediction. Dr. Turakhia has extensive expertise in using large administrative and claims databases for this work. His TREAT-AF retrospective study of over 500,000 patients with newly-diagnosed AF is the largest known research cohort of AF patients. He has served as study PI or chairman of several prominent single- and multicenter trials in atrial fibrillation, investigational devices for electrophysiology procedures, digital health interventions, and sensor technologies.
His other research interests include technology assessment of new device-based therapies and the impact of changing health policy and reform on the delivery of arrhythmia care. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
